Further proof the company isn't dead. Promising results with patient studies regarding autism. I believe 200 patient studies was the number mentioned. Even though Dr. Victor didn't specifically mention SVFC (he did mention ReGen)in the interview with Geraldo, you can bet SVFC is involved in this. This is the beginning of what could be a huge coup for SVFC since Autism is a major disease with no cure. However, we have to remember this study is in its infancy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.